Physician profile
Amanda E Keys
NPI 1215145164
$27,023.33
in general payments reported to CMS, 2019-2025
30 companies · $1,041 in 2025
The $1,041 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,217 · 2022: $7,114 · 2023: $7,146 · 2024: $4,505 · 2025: $1,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Food and Beverage: $4,613 · Travel and Lodging: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Food and Beverage | $4,613.12 |
| Travel and Lodging | $578.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19,667.00 | 2021-2025 | Lifevest |
| Abbott Laboratories | $1,875.64 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Pfizer INC. | $912.38 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $590.21 | 2021-2025 | Leqvio |
| E.R. Squibb & Sons, L.L.C. | $520.27 | 2021-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $437.79 | 2021-2024 | Farxiga, Brilinta |
| Amgen INC. | $402.08 | 2021-2025 | Repatha, Repatha |
| Abiomed | $351.21 | 2024-2025 | Impella |
| Boston Scientific Corporation | $254.29 | 2022-2025 | Watchman, Watchman Flx |
| Merck Sharp & Dohme LLC | $250.77 | 2021-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $239.96 | 2021-2023 | Xarelto |
| Esperion Therapeutics, INC. | $223.74 | 2021-2024 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $211.43 | 2021-2023 | Jardiance |
| Impulse Dynamics (USA) INC. | $159.74 | 2023 | Optimizer |
| Novo Nordisk INC | $128.15 | 2023-2025 | Wegovy, Ozempic |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $121.18 | 2021 | |
| Amarin Pharma, INC. | $109.40 | 2021-2022 | |
| Heartflow, INC. | $98.09 | 2024 | |
| Philips North America LLC | $69.97 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $61.43 | 2025 | Evkeeza |
| Recor Medical INC | $52.33 | 2024 | Paradise Renal Denervation System |
| Silk Road Medical, INC. | $49.64 | 2021-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Sanofi-Aventis U.S. LLC | $47.14 | 2022 | |
| Itamar Medical INC | $41.74 | 2024 | Watchpatone |
| Kiniksa Pharmaceuticals International, Plc | $35.17 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $34.89 | 2025 | Assure Wcd |
| Cvrx, INC. | $23.37 | 2023 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $20.91 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals, Ltd. | $16.77 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $16.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Keys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.